AOD-9604 for fat loss: what the evidence actually shows

What did @livvvvvk actually say?

Liv describes AOD-9604 as an "anti obesity drug" that works by "mimicking natural growth hormone to regulate your fat metabolism." She says it induces lipolysis, prevents future fat storage, and unlike semaglutide, leaves your appetite intact so you can still build muscle. She ends with a discount code and a link to buy.

To her credit, she's accurate on the abbreviation: AOD does stand for anti-obesity drug, and the compound is a synthetic fragment of human growth hormone (hGH), specifically amino acids 176-191. The mechanism description, lipolysis promotion, is grounded in real preclinical data. But the leap from "this works in rats" to "go use my discount code" skips several important steps, including the fact that AOD-9604 failed its pivotal human trials and was never approved by any major regulatory agency for weight loss.

Does the science back this up?

The preclinical data is genuinely interesting, but human evidence is thin. The compound showed promise in animal models, but clinical trials in humans did not replicate those results at a meaningful scale.

AOD-9604 was developed by Metabolic Pharmaceuticals in the early 2000s. In obese mouse models, it did demonstrate lipolytic activity without the hyperglycemic effects associated with full-length hGH (Heffernan et al., 2001, Journal of Endocrinology). That part, Liv gets basically right. The compound does appear to work through beta-3 adrenergic receptors to stimulate fat breakdown, and it does not appear to significantly affect insulin sensitivity in those models.

However, Phase 2 and Phase 3 human clinical trials (METRO studies, Metabolic Pharmaceuticals, 2004-2007) failed to show statistically significant weight loss compared to placebo. The compound was not approved by the FDA or TGA for obesity treatment. It currently has no approved therapeutic use for weight loss in any major jurisdiction. The cartilage regeneration angle is a separate research thread, still largely preclinical.

What did they get wrong (or right)?

Liv gets the mechanism description mostly right and deserves credit for not overstating the insulin sensitivity angle, which is actually one of the more supported claims about AOD-9604. But she makes a critical error of omission: she never mentions the drug failed human trials.

She also says it "induces lipogenesis" which is the opposite of what she means. Lipogenesis is fat creation. She likely meant lipolysis inhibition or anti-lipogenesis. This is a meaningful factual error, not a small one. Lipogenesis and lipolysis are opposing metabolic processes.

The comparison to semaglutide is also misleading. Semaglutide has extensive Phase 3 data showing 15-17% body weight reduction in clinical trials (Wilding et al., 2021, New England Journal of Medicine). AOD-9604 has no comparable human evidence. Framing these as comparable alternatives, where AOD is just the version that lets you keep your appetite, misrepresents the evidence gap between them significantly.

• Got right: AOD-9604 does appear to mimic the lipolytic fragment of hGH
• Got right: It does not appear to strongly affect insulin sensitivity in preclinical models
• Got wrong: Called it something that "induces lipogenesis" when she meant the opposite
• Got wrong: Never disclosed that human trials failed to show significant weight loss
• Problematic: Ends with a purchase link and discount code for an unapproved compound

What should you actually know?

AOD-9604 is not approved by the FDA for any indication. It is not a drug you can get prescribed for weight loss through standard medical channels in the US. That does not mean no one uses it, but it means the safety and efficacy data in humans is far weaker than this video implies.

The compound has an interesting safety profile in the sense that it does not appear to cause the blood sugar dysregulation associated with full hGH. That is genuinely worth noting. But "does not cause one bad thing" is not the same as "is proven to work and is safe long-term." Long-term human safety data does not exist in any robust form.

If you are cutting and want to preserve muscle while losing fat, that is a legitimate goal. There are compounds with actual human trial data behind them. AOD-9604 is not currently one of them. Anyone selling it with a discount code and no mention of its regulatory status or failed trials is not giving you the full picture. A regulated telehealth provider should be your first conversation, not a TikTok bio link.